Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | ACKR3 | P25106 | 1/20 | 0.46 |
| ▸ | DPP4 | P27487 | 1/20 | 0.45 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.45 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.44 |
| ▸ | FAAH | O00519 | 12/20 | 0.43 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.43 |
| ▸ | CCR4 | P51679 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6968264 | 0.90 | OPRK1 (0.56) | LMNASMN1; SMN2TSHRHTTMAPT | |
| SCHEMBL6978779 | 0.90 | OPRK1 (0.56) | LMNASMN1; SMN2TSHRHTTMAPT | |
| SCHEMBL6975047 | 0.88 | OPRK1 (0.48) | LMNASMN1; SMN2TSHRHTTMAPT | |
| SCHEMBL6967773 | 0.87 | CXCR4 (0.47) | LMNASMN1; SMN2TSHRHTTMAPT | |
| SCHEMBL6974472 | 0.86 | LMNA (0.52) | LMNASMN1; SMN2TSHRHTTMAPT | |
| SCHEMBL6978579 | 0.86 | LMNA (0.45) | LMNASMN1; SMN2TSHRHTTMAPT | |
| SCHEMBL6975899 | 0.85 | LMNA (0.49) | LMNASMN1; SMN2TSHRHTTMAPT | |
| SCHEMBL7083455 | 0.85 | LMNA (0.47) | LMNASMN1; SMN2TSHRHTTMAPT | |
| SCHEMBL6974967 | 0.85 | OPRK1 (0.45) | LMNASMN1; SMN2TSHRHTTMAPT | |
| SCHEMBL6971418 | 0.85 | LMNA (0.54) | LMNASMN1; SMN2TSHRHTTMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1100797-B1 | HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ROTAMASE ENZYMES | PFIZER LTD (GB) | 2003-02-26 | — | — | EP | claimed |
| US-6372736-B1 | ENZYME INHIBITORS | PFIZER INC | 2002-04-16 | — | — | US | claimed |
| US-6562964-B1 | Inhibitors of rotamase enzymes in particular FKBP-12 and FKBP-52. The compounds therefore moderate neuronal regeneration and outgrowth and can be used for treating neurological disorders arising from neurodegenerative diseases or other disorders | PFIZER INC | 2003-05-13 | — | — | US | disclosed |
| EP-1100797-B1 | HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ROTAMASE ENZYMES | PFIZER LTD (GB) | 2003-02-26 | — | — | EP | disclosed |
| US-6372736-B1 | ENZYME INHIBITORS | PFIZER INC | 2002-04-16 | — | — | US | disclosed |